Author:
Tsakris A.,Alexiou-Daniel S.,Souliou E.,Antoniadis A.
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference10 articles.
1. Marrie, T. J. (1993). Community-acquired Legionnaires' disease: a reassessment. In Legionella: Current Status and Emerging Perspectives (Barbaree, J. M., Breiman, R. F. & Dufour, A. P., Eds), pp. 46–7. American Society for Microbiology, Washington, DC.
2. Edelstein, P. H. (1995). Antimicrobial chemotherapy for Legionnaires' disease: a review. Clinical Infectious Diseases21Suppl. 3,S265– 76.
3. Unertl, K. E., Lenhart, F. P., Forst, H., Vogler, G., Wilm, V., Ehret, W. et al. (1989). Ciprofloxacin in the treatment of legionellosis in critically ill patients including those cases unresponsive to erythromycin. American Journal of Medicine87Suppl. 5A, S128–31.
4. Onody, C., Matsiota-Bernard, P. & Nauciel, C. (1997). Lack of resistance to erythromycin, rifampicin and ciprofloxacin in 98 clinical isolates of Legionella pneumophila. Journal of Chemotherapy39,815– 6.
5. Baltch, A. L., Smith, R. P. & Ritz, W. (1995). Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampicin used singly and in combination against Legionella pneumophila. Antimicrobial Agents and Chemotherapy39, 1661–6.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献